Vifor commits €25M to nephrology R&D joint venture with Evotec

Vifor commits €25M to nephrology R&D joint venture with Evotec

Source: 
Fierce Biotech
snippet: 

Vifor Pharma has committed €25 million ($28 million) to a nephrology joint venture with Evotec. The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.